NASDAQ · Analyst Forecast

Tevogen Inc. (TVGN) Stock Forecast & Price Target

$5.69 NASDAQ: TVGN Market Cap $23.69M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Tevogen Inc. (TVGN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Tevogen Inc., the average estimate for 2030 earnings per share is $55.00; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$0$0$01
2026$0$0$01
2027$502.27M$502.27M$502.27M1
2028$1.42B$1.42B$1.42B1
2029$307.42M$307.42M$307.42M1
2030$724.49M$724.49M$724.49M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$7.50−$7.50−$7.501
2026−$10.14−$10.14−$10.141
2027−$13.01−$13.01−$13.011
2028−$17.97−$17.97−$17.971
2029$15.50$15.50$15.501
2030$55.00$55.00$55.001

Tevogen Inc. (TVGN) forecast — frequently asked questions

What are analysts forecasting for Tevogen Inc.'s earnings?

The average analyst estimate for Tevogen Inc. (TVGN) earnings per share in 2030 is 55.00, with individual estimates between 55.00 and 55.00.

How much revenue is Tevogen Inc. expected to make?

Analysts forecast Tevogen Inc. (TVGN) revenue of $724.49M in 2030, based on 1 published estimates.

How many analysts cover TVGN?

1 analyst contribute estimates for Tevogen Inc. (TVGN). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.